Clinical Practice; Inflammatory Bowel Diseases; Microbiome in Gastrointestinal and Liver Diseases

“In the last few years, newer pharmacological agents have been added to the armamentarium of therapies for the management of ulcerative colitis,” says Shahnaz Sultan, MD, MHSc, AGAF. Hear more in Monday’s symposium “2019 AGA Guideline Highlights: Probiotics, Iron-Deficiency Anemia, Ulcerative Colitis and More.”